Although we did not quantitate cell scattering or extensively characterise the relative phenotypes of mutants versus controls, our morphological observations are consistent with studies showing decreased epithelial markers and increased mesenchymal markers upon CD44 activation [42], and links between CD44, EMT and breast cancer progression [42]. Here, CD44 is linked to breast carcinoma.